HCM city dismisses rumour of Omicron case
(VOVWORLD) - HCM city’s health authorities on Monday rejected news circulating on the internet about an Omicron variant case in the southern metropolis.

(VOVWORLD) - HCM city’s health authorities on Monday rejected news circulating on the internet about an Omicron variant case in the southern metropolis.

(VOVWORLD) - Microsoft has said it will not participate in person at the Consumer Electronics Show (CES) 2022 in Las Vegas, joining a list of companies opting not to have a physical presence at next month's event on concerns over the rapid spread of the Omicron COVID-19 variant.

(VOVWORLD) - Vietnam confirmed 15,218 new COVID-19 cases on Sunday, the Health Ministry announced.

(VOVWORLD) - Vietnam has given at least one dose of COVID-19 vaccines to about 98% of the population.

(VOVWORLD) - Vietnam confirmed 15,586 new infections of COVID-19 on Saturday, according to the Health Ministry.

(VOVWORLD) - Commercial airlines around the world canceled more than 4,500 flights over the Christmas weekend, as a mounting wave of COVID-19 infections driven by the Omicron variant created greater uncertainty and misery for holiday travelers.

(VOVWORLD) - The Biden administration will lift travel restrictions on eight southern African countries imposed last month over concerns about the fast-spreading COVID-19 Omicron variant, the White House said Friday.

(VOVWORLD) - Vietnam recorded 16,157 new cases of COVID-19, of which 15 were imported and 16,142 were recorded domestically in 62 provinces and cities over the past 24 hours. Hanoi reported the most cases: 1,834.

(VOVWORLD) - The World Health Organisation (WHO) will continue to work with the Government of Vietnam to plan for and transition towards endemic COVID-19 and living safely with the virus long term, even if there are new surges, said Dr. Kidong Park, WHO Representative in Vietnam.

(VOVWORLD) - The US on Thursday authorized Merck & Co's antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving the go-ahead to a similar but more effective treatment from Pfizer.
